semaglutide ema approval Wegovy injection becomes first GLP-1 weight-loss treatment approved for 48-hour controlled-temperature delivery in the EU - NovoNordisk EMA warns Ozempic linked to
Description
And you can see him looking at this as something thats paid off for him

doi: 10.2337/db13-0022

CTCL is a rare type of cancer, affecting 8.55 per 1 million people between 2000 and 2018
According to a 2022 report by Trilliant Health, more than 9 million prescriptions were written for Ozempic, Wegovy and other weight loss medications
